Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 9th March 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

IVC acquires telemedicine provider PawSquad
Dr Mark Boddy, CEO, PawSquad.
Firm will operate as an autonomous entity within the IVC group.

European Veterinary Group IVC Evidensia (IVC) has acquired PawSquad, a veterinary telemedicine provider offering consultations by video and live text chat across the UK.

In a press statement, IVC said that PawSquad 'will continue to operate as an autonomous entity within the IVC group', adding that IVC will continue to serve the needs of pet owners 'regardless of the vet practice they currently visit'. 

Commenting on the acquisition, PawSquad CEO, Dr Mark Boddy, said: “Our network of experienced veterinarians has already helped many thousands of pets in the UK, providing medical advice, emergency triage and preventive health plans. Being part of IVC will allow us to help even more pets and to continue to work positively and collaboratively with the veterinary profession, as well as expand geographically.”

Founded in 2015, PawSquad’s corporate customers and partners currently include Direct Line Insurance, Blue Cross and the PDSA.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.